Sign In

Login

Password

Forgot Password ? Sign Up

Bilastina (Portuguese Wikipedia)

Analysis of information sources in references of the Wikipedia article "Bilastina" in Portuguese language version.

refsWebsite
Global rank Portuguese rank
15doi.org
2nd place
4th place
14nih.gov
4th place
8th place
2wiley.com
222nd place
196th place
1sigmaaldrich.com
924th place
1,291st place
1web.archive.org
1st place
1st place
1drugs.com
399th place
289th place

doi.org

dx.doi.org

  • Corcóstegui R, Labeaga L, Innerárity A, Berisa A, Orjales A (2005). «Preclinical pharmacology of bilastine, a new selective histamine H1 receptor antagonist: Receptor selectivity and in vitro antihistaminic activity». Drugs in R&D. 6 (6): 371–84. PMID 16274260. doi:10.2165/00126839-200506060-00005 
  • Cumulative Nce introduction index, 1983–2010. Col: Annual Reports in Medicinal Chemistry. 46. [S.l.: s.n.] 2011. pp. 531–551. ISBN 9780123860095. doi:10.1016/B978-0-12-386009-5.00035-7 
  • Bousquet J, Ansótegui I, Canonica GW, Zuberbier T, Baena-Cagnani CE, Bachert C, Cruz AA, González SN, Kuna P, Morais-Almeida M, Mullol J, Ryan DP, Sánchez-Borges M, Valiente R, Church MK (2012). «Establishing the place in therapy of bilastine in the treatment of allergic rhinitis according to ARIA: evidence review». Current Medical Research and Opinion. 28 (1): 131–9. PMID 22149770. doi:10.1185/03007995.2011.648263 
  • Bachert C, Kuna P, Sanquer F, Ivan P, Dimitrov V, Gorina MM, van de Heyning P, Loureiro A (2009). «Comparison of the efficacy and safety of bilastine 20 mg vs desloratadine 5 mg in seasonal allergic rhinitis patients». Allergy. 64 (1): 158–65. PMID 19132976. doi:10.1111/j.1398-9995.2008.01813.x 
  • Church MK, Labeaga L (2017). «Bilastine: a new H1 -antihistamine with an optimal profile for updosing in urticaria». J Eur Acad Dermatol Venereol. 31 (9): 1447–1452. PMID 28467671. doi:10.1111/jdv.14305 
  • Horak F, Zieglmayer P, Zieglmayer R, Lemell P (2010). «The effects of bilastine compared with cetirizine, fexofenadine, and placebo on allergen-induced nasal and ocular symptoms in patients exposed to aeroallergen in the Vienna challenge chamber». Inflamm. Res. 59 (5): 391–398. PMID 19943178. doi:10.1007/s00011-009-0117-4 
  • Kuna P, Bachert C, Nowacki Z, van Cauwenberge P, Agache I, Fouquert L, Roger A, Sologuren A, Valiente R (2009). «Efficacy and safety of bilastine 20 mg compared with cetirizine 10 mg and placebo for the symptomatic treatment of seasonal allergic rhinitis: a randomized, double-blind, parallel-group study». Clin. Exp. Allergy. 39 (9): 1338–1347. PMID 19438584. doi:10.1111/j.1365-2222.2009.03257.x 
  • Graff C, Struijk JJ, Kanters JK, Andersen MP, Toft E, Tyl B (2012). «Effects of bilastine on T-wave morphology and the QTc interval: A randomized, double-blind, placebo-controlled, thorough QTc study». Clinical Drug Investigation. 32 (5): 339–51. PMID 22393898. doi:10.2165/11599270-000000000-00000 
  • Tyl B, Kabbaj M, Azzam S, Sologuren A, Valiente R, Reinbolt E, Roupe K, Blanco N, Wheeler W (2012). «Lack of significant effect of bilastine administered at therapeutic and supratherapeutic doses and concomitantly with ketoconazole on ventricular repolarization: Results of a thorough QT study (TQTS) with QT-concentration analysis». Journal of Clinical Pharmacology. 52 (6): 893–903. PMID 21642470. doi:10.1177/0091270011407191 
  • Bachert, C.; Kuna, P.; Zuberbier, T. (1 de junho de 2010). «Bilastine in allergic rhinoconjunctivitis and urticaria». Allergy. 65: 1–13. doi:10.1111/j.1398-9995.2010.02404.x 
  • Bailey DG (2010). «Fruit juice inhibition of uptake transport: a new type of food-drug interaction». Br. J. Clin. Pharmacol. 70 (5): 645–655. PMC 2997304Acessível livremente. PMID 21039758. doi:10.1111/j.1365-2125.2010.03722.x 
  • Corcóstegui R, Labeaga L, Innerárity A, Berisa A, Orjales A (2005). «Preclinical pharmacology of bilastine, a new selective histamine H1 receptor antagonist. Receptor selectivity and in vitro antihistaminic activity». Drugs in R&D. 6 (6): 371–384. PMID 16274260. doi:10.2165/00126839-200506060-00005 
  • Bachert C, Kuna P, Sanquer F, Ivan P, Dimitrov V, Gorina MM, van de Heyning P, Loureiro A (2009). «Comparison of the efficacy and safety of bilastine 20 mg vs desloratadine 5 mg in seasonal allergic rhinitis patients». Allergy. 64 (1): 158–65. PMID 19132976. doi:10.1111/j.1398-9995.2008.01813.x 
  • Jáuregui I, García-Lirio E, Soriano AM, Gamboa PM, Antépara I (1 de janeiro de 2012). «An overview of the novel H1-antihistamine bilastine in allergic rhinitis and urticaria». Expert Review of Clinical Immunology. 8 (1): 33–41. PMID 22149338. doi:10.1586/eci.11.87 
  • Jauregizar N, de la Fuente L, Lucero ML, Sologuren A, Leal N, Rodríguez M (1 de agosto de 2009). «Pharmacokinetic-Pharmacodynamic Modelling of the Antihistaminic (H1) Effect of Bilastine». Clinical Pharmacokinetics. 48 (8): 543–554. PMID 19705924. doi:10.2165/11317180-000000000-00000 

drugs.com

nih.gov

ncbi.nlm.nih.gov

  • Corcóstegui R, Labeaga L, Innerárity A, Berisa A, Orjales A (2005). «Preclinical pharmacology of bilastine, a new selective histamine H1 receptor antagonist: Receptor selectivity and in vitro antihistaminic activity». Drugs in R&D. 6 (6): 371–84. PMID 16274260. doi:10.2165/00126839-200506060-00005 
  • Jáuregui I, Bartra J, del Cuvillo A, Dávila I, Ferrer M, Montoro J, Mullol J, Sastre J, Valero A (2011). «Bilastine and quality of life». Journal of Investigational Allergology and Clinical Immunology. 21 Suppl 3: 16–23. PMID 22185046 
  • Bousquet J, Ansótegui I, Canonica GW, Zuberbier T, Baena-Cagnani CE, Bachert C, Cruz AA, González SN, Kuna P, Morais-Almeida M, Mullol J, Ryan DP, Sánchez-Borges M, Valiente R, Church MK (2012). «Establishing the place in therapy of bilastine in the treatment of allergic rhinitis according to ARIA: evidence review». Current Medical Research and Opinion. 28 (1): 131–9. PMID 22149770. doi:10.1185/03007995.2011.648263 
  • Bachert C, Kuna P, Sanquer F, Ivan P, Dimitrov V, Gorina MM, van de Heyning P, Loureiro A (2009). «Comparison of the efficacy and safety of bilastine 20 mg vs desloratadine 5 mg in seasonal allergic rhinitis patients». Allergy. 64 (1): 158–65. PMID 19132976. doi:10.1111/j.1398-9995.2008.01813.x 
  • Church MK, Labeaga L (2017). «Bilastine: a new H1 -antihistamine with an optimal profile for updosing in urticaria». J Eur Acad Dermatol Venereol. 31 (9): 1447–1452. PMID 28467671. doi:10.1111/jdv.14305 
  • Horak F, Zieglmayer P, Zieglmayer R, Lemell P (2010). «The effects of bilastine compared with cetirizine, fexofenadine, and placebo on allergen-induced nasal and ocular symptoms in patients exposed to aeroallergen in the Vienna challenge chamber». Inflamm. Res. 59 (5): 391–398. PMID 19943178. doi:10.1007/s00011-009-0117-4 
  • Kuna P, Bachert C, Nowacki Z, van Cauwenberge P, Agache I, Fouquert L, Roger A, Sologuren A, Valiente R (2009). «Efficacy and safety of bilastine 20 mg compared with cetirizine 10 mg and placebo for the symptomatic treatment of seasonal allergic rhinitis: a randomized, double-blind, parallel-group study». Clin. Exp. Allergy. 39 (9): 1338–1347. PMID 19438584. doi:10.1111/j.1365-2222.2009.03257.x 
  • Graff C, Struijk JJ, Kanters JK, Andersen MP, Toft E, Tyl B (2012). «Effects of bilastine on T-wave morphology and the QTc interval: A randomized, double-blind, placebo-controlled, thorough QTc study». Clinical Drug Investigation. 32 (5): 339–51. PMID 22393898. doi:10.2165/11599270-000000000-00000 
  • Tyl B, Kabbaj M, Azzam S, Sologuren A, Valiente R, Reinbolt E, Roupe K, Blanco N, Wheeler W (2012). «Lack of significant effect of bilastine administered at therapeutic and supratherapeutic doses and concomitantly with ketoconazole on ventricular repolarization: Results of a thorough QT study (TQTS) with QT-concentration analysis». Journal of Clinical Pharmacology. 52 (6): 893–903. PMID 21642470. doi:10.1177/0091270011407191 
  • Bailey DG (2010). «Fruit juice inhibition of uptake transport: a new type of food-drug interaction». Br. J. Clin. Pharmacol. 70 (5): 645–655. PMC 2997304Acessível livremente. PMID 21039758. doi:10.1111/j.1365-2125.2010.03722.x 
  • Corcóstegui R, Labeaga L, Innerárity A, Berisa A, Orjales A (2005). «Preclinical pharmacology of bilastine, a new selective histamine H1 receptor antagonist. Receptor selectivity and in vitro antihistaminic activity». Drugs in R&D. 6 (6): 371–384. PMID 16274260. doi:10.2165/00126839-200506060-00005 
  • Bachert C, Kuna P, Sanquer F, Ivan P, Dimitrov V, Gorina MM, van de Heyning P, Loureiro A (2009). «Comparison of the efficacy and safety of bilastine 20 mg vs desloratadine 5 mg in seasonal allergic rhinitis patients». Allergy. 64 (1): 158–65. PMID 19132976. doi:10.1111/j.1398-9995.2008.01813.x 
  • Jáuregui I, García-Lirio E, Soriano AM, Gamboa PM, Antépara I (1 de janeiro de 2012). «An overview of the novel H1-antihistamine bilastine in allergic rhinitis and urticaria». Expert Review of Clinical Immunology. 8 (1): 33–41. PMID 22149338. doi:10.1586/eci.11.87 
  • Jauregizar N, de la Fuente L, Lucero ML, Sologuren A, Leal N, Rodríguez M (1 de agosto de 2009). «Pharmacokinetic-Pharmacodynamic Modelling of the Antihistaminic (H1) Effect of Bilastine». Clinical Pharmacokinetics. 48 (8): 543–554. PMID 19705924. doi:10.2165/11317180-000000000-00000 

sigmaaldrich.com

web.archive.org

wiley.com

onlinelibrary.wiley.com

accp1.onlinelibrary.wiley.com